Cannabis Bioscience International Holdings, Inc. (CBIH) stock

CBIHOTCServices-Commercial Physical & Biological ResearchFiscal year ends May 31

Financials through Q3 FY2026, quarter ended Feb 28, 2026Last filing: 10-Q on Apr 16, 2026Score 0/30

$0.00+0.00 (+33.33%)

Close on Oct 19, 2026Market cap $2.33MP/E –Yield –

Cannabis Bioscience International r&d expenses

Research and development expenses are spending on new products and technology.

Cannabis Bioscience International has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

Parsed from the XBRL in Cannabis Bioscience International's annual and quarterly filings with the SEC
Per-share figures adjusted for the 1-for-10 reverse split on Sep 28, 2009
Fourth quarters derived from the annual report minus nine months
Every figure in the statements links to its source filing